Antipyretic TRIZ Cases
- CYLD Upregulation via PDE4 Inhibition for Anti-Inflammatory Therapy
Upregulating CYLD deubiquitinase expression through pharmacological inhibition of its negative regulator PDE4 to modulate inflammatory responses.
- Alpha-MSH Analogue Therapy for Vitiligo Repigmentation
An alpha-MSH analogue composition stimulates melanocytes to produce melanin and restore skin pigmentation.
- Vagus Nerve Stimulation Modulates T-Cell Activity to Inhibit TNF
Stimulating the vagus nerve releases acetylcholine to modulate splenic T-cell activity and suppress inflammatory cytokine production.
- Trimaleimide Linkers for Homogeneous Antibody-Drug Conjugates
Trimaleimide linkers direct site-specific conjugation to antibodies, resolving heterogeneity in drug-to-antibody ratio distribution.
- Pooled Apoptotic Cell Preparation for GVHD Prevention
A pooled mononuclear apoptotic cell preparation induces immune tolerance through controlled apoptosis induction.
- Anti-Tryptase Antibodies for Tryptase Inhibition
Isolated antibodies bind human tryptase beta 1 to inhibit enzymatic activity.
- TOX Biomarker Measurement for SARS-CoV-2 Severity Prediction
Measuring TOX protein levels predicts SARS-CoV-2 severity, addressing insufficient biomarker information in current diagnostic methods.
- Polyelectrolyte Complex for Controlled Release of Charged Actives
A degradable polymer matrix uses an acid-sensitive polyelectrolyte complex to mask hydrophilicity and promote incorporation of charged active principles.
- Stable Topical Analgesic Emulsions for Pain Relief
Magnesium salt and cannabinoid topical compositions deliver localized pain relief through stable water-in-oil emulsion formulations.
- Antibody Purification via Protein A Chromatography
Sequential chromatography steps remove host cell proteins to achieve pharmaceutical-grade antibody purity.
- Humanized Anti-CD89 Antibodies Blocking IgA Binding
Humanized anti-human CD89 antibodies bind the extracellular domain to block IgA interaction, reducing inflammatory responses while maintaining cell viability.
- Artificial Nucleic Acid Molecules With Modified UTR Elements
Modified bases and phosphodiester bonds stabilize mRNA while specific UTR elements enhance protein production without triggering immune responses.
- Naproxen Vitamin B6 Tablet Manufacturing via Segmented Granulation
Segmented wet granulation processes naproxen and vitamin B6 separately before blending, resolving capping defects while maintaining tablet hardness.
- Tetravalent Anti-PSGL-1 Antibodies Enhance Binding Affinity
Tetravalent antibodies bind human PSGL-1 with increased affinity, resolving limited efficacy in treating T-cell mediated inflammatory diseases.
- Anti-LAG-3 Antibodies for Reversible T Cell Regulation
Monoclonal agonistic antibodies bind LAG-3 to inhibit antigen-induced T cell proliferation and activation without depleting cells.
- Angiotensin II Receptor Antagonist Dose Optimization for Fibrosis Inhibition
Lower angiotensin II receptor antagonist doses interfere with mechanotransduction pathways, reducing liver and kidney fibrosis progression.
- Adhesive Patch Spunlace Support Firmness
Spunlace nonwoven supports combined with SIS copolymers and liquid paraffin prevent adhesive exudation while maintaining firmness.
- Anti-CD3 Antibody with Modified Fc Region for Reduced Cytokine Release
Engineered Fc region mutations in anti-CD3 antibodies reduce cytokine release syndrome and toxicity while preserving target cell killing capability.